Related references
Note: Only part of the references are listed.Optimizing levodopa therapy, when and how? Perspectives on the importance of delivery and the potential for an early combination approach
Andrew Lees et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2023)
COMT Inhibitors in the Management of Parkinson's Disease
Margherita Fabbri et al.
CNS DRUGS (2022)
Levodopa-entacapone-carbidopa intestinal gel infusion in advanced Parkinson's disease: real-world experience and practical guidance
Dag Nyholm et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2022)
Non-motor symptoms are associated with REM sleep behavior disorder in Parkinson's disease: a systematic review and meta-analysis
Dan Xie et al.
NEUROLOGICAL SCIENCES (2021)
Fixed-dose combination therapy for Parkinson's disease with a spotlight on entacapone in the past 20 years: a reduced pill burden and a simplified dosing regime
Andras Salamon et al.
EXPERT OPINION ON PHARMACOTHERAPY (2020)
Therapeutic Effect of Levodopa/Carbidopa/Entacapone on Sleep Disturbance in Patients with Parkinson's Disease
Kye Won Park et al.
JOURNAL OF MOVEMENT DISORDERS (2020)
International Parkinson and Movement Disorder Society Evidence-Based Medicine Review: Update on Treatments for the Motor Symptoms of Parkinson's Disease
Susan H. Fox et al.
MOVEMENT DISORDERS (2018)
Efficacy of rasagiline and selegiline in Parkinson's disease: a head-to-head 3-year retrospective case-control study
Emanuele Cereda et al.
JOURNAL OF NEUROLOGY (2017)
Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial
Joaquim J. Ferreira et al.
LANCET NEUROLOGY (2016)
Pooled analysis of phase III with entacapone in Parkinson's disease
M. Kuoppamaki et al.
ACTA NEUROLOGICA SCANDINAVICA (2014)
Quality of life in Parkinson's disease patients with motor fluctuations and dyskinesias in five European countries
Marlene C. Hechtner et al.
PARKINSONISM & RELATED DISORDERS (2014)
Nonmotor fluctuations in Parkinson disease Severity and correlation with motor complications
Alexander Storch et al.
NEUROLOGY (2013)
The effect of different dosing regimens of levodopa/carbidopa/entacapone on plasma levodopa concentrations
Kimmo Ingman et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Night-time bioavailability of levodopa/carbidopa/entacapone is higher compared to controlled-release levodopa/carbidopa
M. Kuoppamäki et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2011)
Direct switch from levodopa/benserazide or levodopa/carbidopa to levodopa/carbidopa/entacapone in Parkinson's disease patients with wearing-off: efficacy, safety and feasibility-an open-label, 6-week study
Karla Eggert et al.
JOURNAL OF NEURAL TRANSMISSION (2010)
Comparison of pharmacokinetic profile of levodopa throughout the day between levodopa/carbidopa/entacapone and levodopa/carbidopa when administered four or five times daily
Mikko Kuoppamaki et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Early versus delayed initiation of entacapone in levodopa-treated patients with Parkinson's disease: a long-term, retrospective analysis
H. Nissinen et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
Double-Blind Trial of Levodopa/Carbidopa/Entacapone Versus Levodopa/Carbidopa in Early Parkinson's Disease
Robert A. Hauser et al.
MOVEMENT DISORDERS (2009)
Entacapone prolongs the reduction of PLM by levodopa/carbidopa in restless legs syndrome
Olli Polo et al.
CLINICAL NEUROPHARMACOLOGY (2007)
Patient satisfaction with switching to Stalevo:: an open-label evaluation in PD patients experiencing wearing-off (Simcom Study)
V. Myllyla et al.
ACTA NEUROLOGICA SCANDINAVICA (2006)
Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial
O Rascol et al.
LANCET (2005)
Entacapone is beneficial in both fluctuating and non-fluctuating patients with Parkinson's disease: a randomised, placebo controlled, double blind, six month study
DJ Brooks et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2003)
Excessive daytime sleepiness and 'sleep attacks' induced by entacapone
M Bares et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2003)
Efficacy and tolerability of entacapone as adjunctive therapy to levodopa in patients with Parkinson's disease and end-of-dose deterioration in daily medical practice: An open, multicenter study
F Durif et al.
EUROPEAN NEUROLOGY (2001)
Share Paper
